BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25796508)

  • 1. Seroprevalence of Pandemic A(H1N1) pmd09 Virus Antibodies in Mexican Health Care Workers Before and After Vaccination.
    Aguilar-Madrid G; Castelán-Vega JA; Juárez-Pérez CA; Ribas-Aparicio RM; Estrada-García I; Baltierra-Jasso L; Cervantes-Servín N; Méndez-Ortega V; Haro-García LC; Sánchez-Román FR; Ortiz-Navarrete V; Fabila-Castillo LH; Magaña-Hernández A; Chávez-Negrete A; Salamanca-Gómez FA; Jiménez-Alberto A
    Arch Med Res; 2015 Feb; 46(2):154-63. PubMed ID: 25796508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.
    Veguilla V; López-Gatell H; López-Martínez I; Aparicio-Antonio R; Barrera-Badillo G; Rojo-Medina J; Gross FL; Jefferson SN; Katz JM; Hernández-Ávila M; Alpuche-Aranda CM
    PLoS One; 2016; 11(3):e0150428. PubMed ID: 27003409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010.
    Njuguna H; Ahmed J; Oria PA; Arunga G; Williamson J; Kosgey A; Muthoka P; Mott JA; Breiman RF; Katz MA
    Vaccine; 2013 Sep; 31(41):4662-7. PubMed ID: 23859843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pandemic 2009 influenza A (H1N1) virus among Japanese healthcare workers: seroprevalence and risk factors.
    Nukui Y; Hatakeyama S; Kitazawa T; Mahira T; Shintani Y; Moriya K
    Infect Control Hosp Epidemiol; 2012 Jan; 33(1):58-62. PubMed ID: 22173523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany.
    Cramer J; Mac T; Hogan B; Stauga S; Eberhardt S; Wichmann O; Mertens T; Burchard G
    Euro Surveill; 2012 Jan; 17(2):. PubMed ID: 22264864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-pandemic seroprevalence of 2009 pandemic influenza A (H1N1) virus in Shandong Province, China.
    Liu T; Li Z; Song S; Zhang S; Wang Y; Lin Y; Wang S; Wang X; Xu A; Bi Z
    Jpn J Infect Dis; 2012; 65(5):410-4. PubMed ID: 22996214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of pandemic H1N1 antibody among health care workers in Hong Kong following receipt of monovalent 2009 H1N1 influenza vaccine.
    Zhou Y; Ng DM; Seto WH; Ip DK; Kwok HK; Ma ES; Ng S; Lau LL; Peiris JS; Cowling BJ
    PLoS One; 2011; 6(11):e27169. PubMed ID: 22102878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of influenza A (H1N1) seropositivity in unvaccinated healthcare workers in Scotland at the height of the global pandemic.
    Smith K; Warner P; Williams LJ; Adamson WE; Katikireddi SV; Dewart P; Carman WF; Templeton K; Denison FC; Mackenzie DG
    J Environ Public Health; 2011; 2011():407505. PubMed ID: 21977047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine.
    Valero-Pacheco N; Pérez-Toledo M; Villasís-Keever MÁ; Núñez-Valencia A; Boscó-Gárate I; Lozano-Dubernard B; Lara-Puente H; Espitia C; Alpuche-Aranda C; Bonifaz LC; Arriaga-Pizano L; Pastelin-Palacios R; Isibasi A; López-Macías C
    PLoS One; 2016; 11(2):e0150146. PubMed ID: 26919288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza vaccination and intention to receive the pandemic H1N1 influenza vaccine among healthcare workers of British Columbia, Canada: a cross-sectional study.
    Kaboli F; Astrakianakis G; Li G; Guzman J; Donovan T; Naus M
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1017-24. PubMed ID: 20707670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pandemic influenza A(H1N1)pdm09: risk of infection in primary healthcare workers.
    Hudson B; Toop L; Mangin D; Brunton C; Jennings L; Fletcher L
    Br J Gen Pract; 2013 Jun; 63(611):e416-22. PubMed ID: 23735413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained low influenza vaccination in health care workers after H1N1 pandemic: a cross sectional study in an Italian health care setting for at-risk patients.
    Giannattasio A; Mariano M; Romano R; Chiatto F; Liguoro I; Borgia G; Guarino A; Lo Vecchio A
    BMC Infect Dis; 2015 Aug; 15():329. PubMed ID: 26265328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence following the first wave of pandemic influenza A (H1N1) in Turkey, 2009.
    Gözalan A; Altaş AB; Sevencan F; Akın L; Korukluoğlu G; Kara S; Sevindi DF; Ertek M;
    Jpn J Infect Dis; 2012; 65(1):13-8. PubMed ID: 22274152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre- and post-pandemic prevalence of antibodies to the 2009 pandemic influenza A (H1N1) virus in Austrian adults.
    Poeppl W; Poeppl G; Hunger M; Tobudic S; Winkler H; Faas A; Mooseder G; Burgmann H
    J Med Virol; 2012 Sep; 84(9):1331-4. PubMed ID: 22825809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pandemic influenza A/H1N1 2009 antibodies in the metropolitan area of Buenos Aires in Argentina.
    Labato MI; Contrini MM; Lazzarini D; Campos AM; Gauna ML; Claros R; López EL; Savy VL; Luna CM
    Int J Infect Dis; 2014 Feb; 19():20-5. PubMed ID: 24211378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Attitudes and side effects related to pandemic influenza A (H1N1) vaccination in healthcare personnel].
    Ormen B; Türker N; Vardar I; Kaptan F; El S; Ural S; Kaya F; Coşkun NA
    Mikrobiyol Bul; 2012 Jan; 46(1):57-64. PubMed ID: 22399172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of influenza A H1N1 and seroconversion of mothers and infants induced by a single dose of monovalent vaccine.
    Chao A; Huang YC; Chang YL; Wang TH; Chang SD; Wu TS; Wu TL; Chao AS
    Taiwan J Obstet Gynecol; 2013 Sep; 52(3):356-9. PubMed ID: 24075373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among hospital staff in a medical center in Taiwan.
    Chan YJ; Lee CL; Hwang SJ; Fung CP; Wang FD; Yen DH; Tsai CH; Chen YM; Lee SD
    J Chin Med Assoc; 2010 Feb; 73(2):62-6. PubMed ID: 20171584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.